Skip to main content
SpringerLink
Log in

CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

CCR6 expression is deregulated in some human malignancies and may be involved in the tumor progression. The aim of the present study was to determine the CCR6 expression in gastric cancer (GC) and to clarify its clinical significance.

Methods

We used western blotting to examine CCR6 protein expression in GC tissues and matched adjacent non-tumor tissues. Immunohistochemistry was performed on a large cohort of 372 postoperative GC samples. Chi-square test, Kaplan–Meier analysis and Cox regression model were used to analyze the data.

Results

Upregulated CCR6 protein expression was observed in the GC tissues by western blotting compared with the adjacent non-cancerous gastric tissues. High CCR6 expression was detected in 56.5 % (210/372) samples and significantly associated with the extracapsular extension of the tumor, tumor relapse and poor overall survival in GC (P < 0.001). Further analysis demonstrated that the CCR6 expression level stratified the patient outcome in stage II, stage III, T3/4, N positive and poorly differentiated/undifferentiated tumor subgroups. The Cox regression analysis showed that high expression of CCR6 was an independent prognostic factor for GC patients.

Conclusions

CCR6 expression may be a novel biomarker for predicting clinical outcomes for GC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Zhang L, Tian W, Kim S, Ding W, Tong Y, Chen S. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo. Drug Des Devel Ther. 2014;9:79–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199–206.

    Article  PubMed  Google Scholar 

  3. Song KY, Park SM, Kim SN, Park CH. The role of surgery in the treatment of recurrent gastric cancer. Am J Surg. 2008;196:19–22.

    Article  PubMed  Google Scholar 

  4. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem. 1997;272:5846–53.

    Article  CAS  PubMed  Google Scholar 

  5. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol. 2006;24:1910–6.

    Article  CAS  PubMed  Google Scholar 

  6. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol. 2006;27:166–74.

    Article  CAS  PubMed  Google Scholar 

  7. Frick VO, Rubie C, Kölsch K, Wagner M, Ghadjar P, Graeber S, et al. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand J Immunol. 2013;78:298–305.

    Article  CAS  PubMed  Google Scholar 

  8. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14:409–26.

    Article  CAS  PubMed  Google Scholar 

  9. Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3 alpha (Mip-3 alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J. 2004;10:374–80.

    Article  CAS  PubMed  Google Scholar 

  10. Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, et al. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol. 2008;134:1181–9.

    Article  CAS  PubMed  Google Scholar 

  11. Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Graeber S, et al. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol. 2011;17:3109–16.

    PubMed  PubMed Central  Google Scholar 

  12. Wang L, Qin H, Li L, Zhang Y, Tu Y, Feng F, et al. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas. Med Oncol. 2012;29:3491–7.

    Article  CAS  PubMed  Google Scholar 

  13. Kirshberg S, Izhar U, Amir G, Demma J, Vernea F, Beider K, et al. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression. PLoS One. 2011;6:e24856.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Surgery Department, Qilu Hospital, Shandong University, No 107 Jinan West Wenhua Road, Jinan, 250012, China

    X. G. Zhang, F. J. Liu, D. Sun, K. X. Wang & H. Qu

  2. Emergency Department, The Central Hospital of Shengli Oil Field, Dongying, 257000, China

    X. G. Zhang

  3. General Surgery Department, Affiliated Hospital of Binzhou Medical University, Binzhou, 256603, Shandong, China

    B. T. Song

Authors
  1. X. G. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. T. Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. J. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. X. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. J. Liu.

Ethics declarations

Informed consent

Written informed consent was obtained from all the patients. The present study was approved by the Ethics Committee of Shandong University, Shandong, China.

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X.G., Song, B.T., Liu, F.J. et al. CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Clin Transl Oncol 18, 700–707 (2016). https://doi.org/10.1007/s12094-015-1420-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-015-1420-x

Keywords

Search

Navigation